Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Assets Average (2020 - 2025)

Historic Assets Average for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to $88.2 million.

  • Biodesix's Assets Average fell 1927.04% to $88.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $88.2 million, marking a year-over-year decrease of 1927.04%. This contributed to the annual value of $98.2 million for FY2024, which is 225.94% up from last year.
  • Per Biodesix's latest filing, its Assets Average stood at $88.2 million for Q3 2025, which was down 1927.04% from $87.0 million recorded in Q2 2025.
  • Biodesix's Assets Average's 5-year high stood at $118.3 million during Q1 2021, with a 5-year trough of $68.4 million in Q2 2022.
  • In the last 5 years, Biodesix's Assets Average had a median value of $88.2 million in 2025 and averaged $89.6 million.
  • As far as peak fluctuations go, Biodesix's Assets Average crashed by 4176.94% in 2022, and later skyrocketed by 3295.14% in 2024.
  • Over the past 5 years, Biodesix's Assets Average (Quarter) stood at $83.0 million in 2021, then decreased by 6.01% to $78.1 million in 2022, then increased by 19.08% to $92.9 million in 2023, then rose by 7.59% to $100.0 million in 2024, then decreased by 11.76% to $88.2 million in 2025.
  • Its Assets Average was $88.2 million in Q3 2025, compared to $87.0 million in Q2 2025 and $91.7 million in Q1 2025.